Preeclampsia With Rapidly Falling Platelets: Neuraxial or General Anesthesia?
A 34-year-old woman, G2P1, at 34+2 weeks' gestation is admitted with a blood pressure of 168/112 mmHg, severe headache, and visual scotomata. She is on a magnesium sulfate infusion at 2 g/h. Laboratory results show platelets 86,000/µL (down from 142,000/µL six hours earlier), AST 112 U/L, ALT 98 U/L, creatinine 1.1 mg/dL, and fibrinogen 280 mg/dL. Urine protein-to-creatinine ratio is 1.4. The fetal heart tracing shows recurrent late decelerations, and the obstetrician requests category-1 cesarean delivery. The patient is 160 cm tall and weighs 92 kg; her airway examination shows a Mallampati 3 view, full dentition, and mild facial edema. She is receiving labetalol and has no history of bleeding disorder or anticoagulant use. The neonatologist is present.
1. Would you choose neuraxial anesthesia or general anesthesia for this cesarean delivery? Explain your reasoning using the platelet count, the trend, and the airway findings.
Read the worked answer
This is a judgement between the risk of spinal-epidural hematoma and the risk of a difficult general anesthetic. A platelet count of 86,000/µL is above the commonly used threshold of 70,000–80,000/µL, and preeclampsia itself does not usually cause a coagulopathy unless there is HELLP syndrome or abruption. However, the count has fallen rapidly from 142,000/µL in six hours, which raises concern for developing HELLP syndrome and makes a single number less reassuring. I would repeat the platelet count immediately, check the fibrinogen and peripheral smear, and look for clinical bleeding. If the repeat count is stable above 80,000/µL, the fibrinogen is normal, and there is no coagulopathy, I would proceed with a single-shot spinal using a small-gauge needle, because general anesthesia carries a high risk of severe hypertension, airway edema, and failed intubation in this patient. If the count is below 80,000/µL or falling further, I would choose general anesthesia with a prepared difficult-airway plan.
The Mallampati 3 view and facial edema increase the risk of failed intubation, which is why avoiding general anesthesia is desirable, but the hematoma risk is not negligible. The decision must be individualized, and I would involve the obstetrician and hematologist if needed.
2. If general anesthesia is required, how does magnesium sulfate alter your choice and dosing of neuromuscular blockers? What else would you monitor?
Read the worked answer
Magnesium sulfate potentiates non-depolarizing neuromuscular blockers by reducing presynaptic acetylcholine release and decreasing postjunctional sensitivity. Therefore I would reduce the rocuronium intubating dose by approximately 30–50% and titrate to train-of-four monitoring rather than giving a fixed 1 mg/kg dose. For rapid-sequence induction I still need reliable intubating conditions, so I would give a reduced but adequate dose, such as rocuronium 0.6 mg/kg, and confirm with a train-of-four before attempting intubation if time allows. Magnesium also prolongs succinylcholine blockade, so if succinylcholine is used, I would anticipate prolonged paralysis and monitor accordingly.
I would monitor deep tendon reflexes, respiratory rate, urine output, and magnesium levels for toxicity, because loss of reflexes and respiratory depression precede cardiac arrest. I would also monitor blood pressure closely because magnesium causes vasodilation, and I would have calcium gluconate available. The key judgement is that the patient's magnesium infusion is not a reason to avoid general anesthesia when it is indicated, but it requires altered dosing and objective monitoring.
3. After delivery, what are your priorities for uterine tone, blood pressure control, and analgesia? What would you avoid?
Read the worked answer
After delivery, I would give oxytocin as a dilute infusion rather than a rapid undiluted bolus, because bolus oxytocin can cause profound hypotension and tachycardia. I would avoid ergometrine and methylergonovine because they can cause severe hypertension in preeclampsia. For refractory uterine atony, I would use carboprost with caution in asthma and misoprostol, and consider tranexamic acid. I would control blood pressure with labetalol, hydralazine, or nifedipine, and continue magnesium sulfate for 24 hours postpartum because the risk of eclampsia persists.
For analgesia, if neuraxial anesthesia was used and platelets are stable, I would use intrathecal or epidural morphine with multimodal acetaminophen and judicious opioids. I would avoid NSAIDs if platelets are low or renal function is impaired. I would monitor for postpartum hemorrhage, pulmonary edema, and magnesium toxicity. The judgement is to treat pain and hypertension without causing uterine atony or worsening the coagulopathy, and to involve the obstetric team in a shared plan.